Cstone Pharmaceuticals
Clinical trials sponsored by Cstone Pharmaceuticals, explained in plain language.
-
New hope for lung cancer patients who have run out of options
Disease control OngoingThis study tests a drug called lorlatinib in 70 people in China with a certain type of advanced lung cancer (ROS1-positive) that has gotten worse after other treatments. The goal is to see if the drug can shrink tumors. Participants take lorlatinib pills and are monitored for sid…
Phase: PHASE2 • Sponsor: CStone Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 07:59 UTC
-
New hope for liver cancer: drug duo targets advanced disease
Disease control OngoingThis study tests whether adding the experimental drug nofazinlimab to standard lenvatinib therapy helps people with advanced liver cancer live longer. About 534 adults who cannot have surgery or other local treatments will receive either the combo or a placebo plus lenvatinib. Th…
Phase: PHASE3 • Sponsor: CStone Pharmaceuticals • Aim: Disease control
Last updated May 06, 2026 16:01 UTC